Betaseron and Urinary Incontinence

This page shows results related to Betaseron and Urinary Incontinence from the FDA Adverse Event Reporting System (AERS).

Adverse Event

Safe Use Tools

Learn More

Comments

Betaseron and Urinary Incontinence

Age

50-59 Years	43
40-49 Years	31
30-39 Years	22
>60 Years	20
20-29 Years	12
10-19 Years	4

Gender

Male: 25%
Female: 75%

Outcome

What were the most common outcomes of those reporting Urinary Incontinence?

Other	76
Hospitalization	73
Death	10
Disability	7
Required Intervention	2

Reporter

Who most commonly reported Urinary Incontinence?

Consumer	72
Physician	20
Other	7

Therapy

Of those reporting Urinary Incontinence, why were they taking Betaseron?

Relapsing-remitting Multiple Sclero...	43
Multiple Sclerosis	41
Secondary Progressive Multiple Scle...	15
Progressive Multiple Sclerosis	3
Primary Progressive Multiple Sclero...	2

Other Medications

Which medications reported to the FDA are most commonly associated with Urinary Incontinence?

Fosamax	1278
Avonex	848
Tysabri	720
Zometa	540
Vioxx	455
	Show More
Lyrica	343
Rebif	328
Aredia	253
Detrol La	226
Clozaril	222
Alendronate Sodium	199
Forteo	168
Humira	162
Zyprexa	161
Seroquel	154
Betaseron	153
Risperdal	145
Enbrel	142
Stromectol	142
Remicade	139
Fosamax Plus D	138
Cymbalta	132
Toviaz	128
Namenda	125
Abilify	107
Digoxin	106
Clozapine	100
Risperidone	96
Sandostatin Lar	95
Boniva	95
Methotrexate	95
Exelon	93
Neurontin	91
Flomax	91
Oxycontin	88
Lipitor	87
Vesicare	75
Chantix	68
Spiriva	65
Duragesic-100	65
Strattera	65
Celebrex	65
Enablex	60
Zoloft	59
Mirena	58
Reclast	57
Xanax	55
Lisinopril	54
Tegretol	54
Lioresal	54
Betaferon	53

Is the adverse drug reaction you’re experiencing actually due to the drug you took?

The Naranjo Scale is a questionnaire for determining the likelihood of whether an adverse drug reaction is actually due to the drug or caused by other factors. Probability is assigned via a score termed definite, probable, possible or doubtful.^*

	YES	NO	UNKOWN
Are there previous conclusive reports on this reaction?
Did the adverse event appear after the suspected drug was administered?
Did the adverse reaction improve when the drug was discontinued or a specific antagonist was administered?
Did the adverse reaction reappear when the drug was readministered?
Are there alternative causes (other than the drug) that could on their own have caused the reaction?
Did the reaction reappear when a placebo was given?
Was the drug detected in the blood (or other fluids) in concentrations known to be toxic?
Was the reaction more severe when the dose was increased, or less severe when the dose was decreased?
Did the patient have a similar reaction to the same or similar drugs in any previous exposure?
Was the adverse event confirmed by any objective evidence?

Probability of an Adverse Event

Doubtful

Possible

Probable

Definite

^*Naranjo, et al. "A method for estimating the probability of adverse drug reactions." Clin Pharmacol Ther. 1981 Aug;30(2):239-45.

To learn more about all adverse events for Betaseron, view the complete Betaseron adverse event report.

Scientific Publications on Urinary Incontinence

Comments

Share your experience with Betaseron and Urinary Incontinence.